Add to ORKGRandomized controlled trials designed to test cancer therapies often fail to clarify effectiveness in real-world settings. Herein, we explore lessons for trial development in oncology that can be learnt from the large-cohort, pragmatic RECOVERY trial involving patients hospitalized with COVID-19
The scientific community has risen to the coronavirus disease 2019 (COVID-19) challenge, coming up w...
During the first quarter of 2020 the world is experiencing a pandemic of Severe Acute Respiratory Sy...
We propose platform trials with outcome-adaptive randomization to efficiently select the most effect...
International audienceUnique challenges arise when conducting trials to evaluate therapies already i...
The COVID-19 pandemic affected many activities in the healthcare system including oncology drug deve...
When COVID-19 hit the UK in early 2020, there were no known treatments for a condition that results ...
COVID-19 pandemic; OncologyPandemia de COVID-19; OncologíaPandèmia de COVID-19; OncologiaIn this pap...
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial was set up in March 2020 to evaluate ...
The coronavirus disease-19 (COVID-19) pandemic promises to have lasting impacts on cancer clinical t...
Oncology drug discovery and proper conduct of cancer clinical trials are essential to our battle aga...
Background: The COVID-19 pandemic has forced rapid system-wide changes to be implemented within canc...
RATIONALE: Uncertainty regarding the natural history of coronavirus disease 2019 (COVID-19) led to d...
BackgroundPatients with cancer are particularly vulnerable in the current COVID-19 pandemic. Emergin...
BACKGROUND: Clinical trials, conducted efficiently and with the utmost integrity, are a key componen...
Abstract Background Cancer and chronic diseases are a major cost to the healthcare system and multid...
The scientific community has risen to the coronavirus disease 2019 (COVID-19) challenge, coming up w...
During the first quarter of 2020 the world is experiencing a pandemic of Severe Acute Respiratory Sy...
We propose platform trials with outcome-adaptive randomization to efficiently select the most effect...
International audienceUnique challenges arise when conducting trials to evaluate therapies already i...
The COVID-19 pandemic affected many activities in the healthcare system including oncology drug deve...
When COVID-19 hit the UK in early 2020, there were no known treatments for a condition that results ...
COVID-19 pandemic; OncologyPandemia de COVID-19; OncologíaPandèmia de COVID-19; OncologiaIn this pap...
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial was set up in March 2020 to evaluate ...
The coronavirus disease-19 (COVID-19) pandemic promises to have lasting impacts on cancer clinical t...
Oncology drug discovery and proper conduct of cancer clinical trials are essential to our battle aga...
Background: The COVID-19 pandemic has forced rapid system-wide changes to be implemented within canc...
RATIONALE: Uncertainty regarding the natural history of coronavirus disease 2019 (COVID-19) led to d...
BackgroundPatients with cancer are particularly vulnerable in the current COVID-19 pandemic. Emergin...
BACKGROUND: Clinical trials, conducted efficiently and with the utmost integrity, are a key componen...
Abstract Background Cancer and chronic diseases are a major cost to the healthcare system and multid...
The scientific community has risen to the coronavirus disease 2019 (COVID-19) challenge, coming up w...
During the first quarter of 2020 the world is experiencing a pandemic of Severe Acute Respiratory Sy...
We propose platform trials with outcome-adaptive randomization to efficiently select the most effect...